A rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Gene
; 526(2): 239-45, 2013 Sep 10.
Article
em En
| MEDLINE
| ID: mdl-23570880
Palavras-chave
17-OHP; 17-hydroxyprogesterone; 21-Hydroxylase deficiency; 21-hydroxylase deficiency; 21OHD; 30-kb deletion; 3' untranslated; 3'UTR; 5' untranslated; 5'UTR; ACTH; ASO-PCR; Adrenocorticotropic Hormone; CAH; CYP21A1P; CYP21A2 gene; Congenital adrenal hyperplasia; DHEAS; Dehydroepiandrosterone Sulfate; MLPA; Multiplex Ligation dependent Probe Amplification; NC; RCCX module; RFLP; RP, C4, CYP21 and TNX genes; SV; SW; allele specific oligonucleotide polymerase chain reaction; congenital adrenal hyperplasia; deletion of 30-kb including 3'-end CYP21A1P, C4B, and 5'-end CYP21A2; non-classical; restriction fragment length polymorphism; salt-wasting; simple-virilizing
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Esteroide 21-Hidroxilase
/
Mutação Puntual
/
Hiperplasia Suprarrenal Congênita
Tipo de estudo:
Diagnostic_studies
/
Prognostic_studies
Limite:
Adolescent
/
Adult
/
Child
/
Child, preschool
/
Humans
/
Infant
/
Newborn
Idioma:
En
Revista:
Gene
Ano de publicação:
2013
Tipo de documento:
Article
País de afiliação:
Brasil
País de publicação:
Holanda